Back to Podcast
Power Hour #14 Neutral

Power Hour #14: 235 Bull Signals, 75% of Stocks Underwater: The Breadth Illusion Hiding in Plain Sight – Monday 3/16/2026

March 16, 2026 6:47
Episode Summary
Today's tape is flashing 235 bullish signals — but three out of four stocks are below their 20-day moving average. The hosts break down the dangerous breadth illusion driving the headline numbers, identify Energy as the only sector with real institutional conviction, and walk through exactly which individual setups are worth trading versus which ones are traps. With sixty minutes to the bell, listeners get a precise, actionable playbook for the close and tomorrow's open.
Key Takeaways
  • Energy sector hits 84th percentile leading risk-on rotation
  • Consumer Discretionary in 11th percentile shows sector weakness
  • Biotech momentum builds on FDA approvals and catalysts
  • Market breadth bullish but participation remains narrow
  • Technology bounces back while defensives continue lagging
0:00 / 6:47

Regime Check — Where Are We Now?

Market breadth remains cautiously bullish with 235 bull 4% signals versus 43 bear signals, but underlying structure shows weakness with only 25% of stocks above their 20-day SMA.

  • Breadth expanding modestly on the surface but participation remains narrow — classic late-cycle behavior
  • Technology bouncing back (+2.2% today) while Consumer Discretionary (-2.16%) and Healthcare continue bleeding
  • Energy sector (+4.8, 84th percentile) providing leadership while defensive sectors lag — risk-on rotation intact

Strategy Signals — Continuation, Reversal & SIP

  • 2LYNCH continuation leader: CCUP exploding +18.2% on 0.9 RVOL — high-risk but momentum play into close
  • Reversal setup: CTGO showing bullish divergence with 2.1 RVOL despite flat price action — watch for afternoon breakout
  • SIP movers: BABA (+1.39% gap) on Ant Group approval holding gains, while CF bleeding on litigation settlement
  • BBT action code: Volume surging in biotech names like IMMX (+6.8%, 1.7 RVOL) and COGT on FDA approval

Closing Playbook — What To Do Now

  • Close positions: Any Consumer Discretionary longs showing weakness — sector in 11th percentile and falling
  • Enter on confirmation: Energy names like AMPX (+4.5%) if they hold above morning highs into close
  • Key level: If SPY holds current levels with Energy leading, expect continued risk-on rotation tomorrow

Tomorrow’s Early Look

  • Watch for any biotech momentum follow-through after today’s FDA approval catalyst in COGT
  • Setup forming: BABA consolidating around $135 — break above could target $140 on acquisition news
  • Regime outlook unchanged — selective momentum in pockets while broad market remains choppy and narrow
Share:

Find momentum stocks in milliseconds

Try WaveFinder